Lineage Cell Therapeutics, Inc.

LCTX

Lineage Cell Therapeutics, Inc.

LCTX

Insider Sentiment (TTM):

Last Purchase:2026-03-12Last Sale:-Shares Purchased (TTM):15,000Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:111,153,671Shares Outstanding:245,029,000Institutional Ownership Pct.:45.36%

Earnings Market Reaction:

Filing Date:2026-08-06Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	37	36	41	40	42	48	46	28	30	44	35	31
Marketable Securities Current	13	17	15	0	0	0	2	5	9	0	0	10
Accounts Receivable Net Current	1	1	1	0	0	0	1	0	0	0	1	0
Prepaid Expense And Other Assets Current	1	2	2	2	1	2	3	1	2	2	2	2
Assets Current	53	56	59	42	44	50	51	34	40	46	38	43
Assets Noncurrent
Property Plant And Equipment Net	3	2	3	2	2	2	2	2	2	2	2	5
Deposits Assets Noncurrent	-	-	-	-	-	-	-	-	-	-	-	1
Operating Lease Right Of Use Asset	2	2	2	2	2	2	2	2	3	3	3	-
Goodwill	11	11	11	11	11	11	11	11	11	11	11	11
Intangible Assets Net Excluding Goodwill	32	32	32	32	32	47	47	47	47	47	47	47
Deferred Income Tax Assets Net	6	6	6	-	-	-	0	-	-	-	-	-
Assets	106	110	113	90	91	112	113	97	103	108	101	106
Liabilities And Stockhold…
Liabilities Current
Accounts Payable And Accrued Liabilities Current	5	6	7	5	4	5	5	4	5	6	6	5
Operating Lease Liability Current	1	1	1	1	1	1	1	1	1	1	1	1
Finance Lease Liability Current	-	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue Current	2	2	3	4	5	7	7	8	9	10	11	10
Liabilities Current	8	8	11	9	11	13	14	14	15	17	18	16
Liabilities Noncurrent
Contract With Customer Liability Noncurrent	-	-	-	-	-	-	-	-	-	-	-	21
Deferred Income Tax Liabilities Net	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue Noncurrent	12	13	12	12	13	14	14	16	19	18	19	-
Operating Lease Liability Noncurrent	1	2	2	2	1	1	1	2	2	2	2	2
Other Liabilities Noncurrent	-	-	-	-	-	-	-	-	-	-	0	-
Finance Lease Liability Noncurrent	-	0	0	0	0	0	0	0	0	0	0	0
Derivative Liabilities Noncurrent	25	34	44	45	19	6	6	-	-	-	0	-
Liabilities	46	57	69	69	44	34	36	32	36	37	39	39
Stockholders Equity Inclu…
Common Stock Value	536	530	515	494	491	489	485	469	468	467	451	450
Accumulated Other Comprehensive Income Loss Net Of…	-4	-4	-4	-4	-4	-3	-3	-3	-2	-3	-3	-2
Retained Earnings Accumulated Deficit	-470	-472	-467	-468	-438	-408	-403	-400	-397	-391	-385	-380
Stockholders Equity	61	53	43	22	47	78	77	65	67	71	62	68
Minority Interest	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1	-1
Liabilities And Stockholders Equity	106	110	113	90	91	112	113	97	103	108	101	106
Preferred Stock No Par Value	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	2	2	2	2	2	2	2	2	2	2	2	2
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock No Par Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	450	450	450	450	450	450	450	450	450	450	450	450
Common Stock Shares Issued	253	249	243	230	228	228	220	189	189	189	175	175
Shares Outstanding	253	249	243	230	228	228	220	189	189	189	175	175

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-10.53%	1.50%	-18.80%	-	-	-	-	-	-	-	-	-
2025	44.68%	114.89%	110.64%	20.79%	67.33%	90.10%	1.73%	-4.62%	-6.94%	-19.02%	-15.76%	-29.35%
2024	-15.25%	-15.25%	-13.56%	0.00%	4.55%	-4.55%	-33.71%	-33.71%	-32.58%	-18.87%	-7.55%	24.53%
2023	-	-	-	-4.96%	-16.31%	-19.86%	-7.48%	1.87%	2.80%	30.97%	0.88%	-7.08%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	6.61	6.89	5.20	4.50	4.08	3.82	3.65	2.48	2.64	2.71	2.14	2.74
Quick Ratio	6.44	6.65	4.99	4.33	3.96	3.68	3.47	2.39	2.54	2.59	2.02	2.63
Working Capital	44.95M	48.02M	47.79M	32.88M	33.09M	36.90M	37.02M	20.54M	25.12M	28.83M	20.48M	27.60M
Leverage & Debt
Debt to Equity	0.76	1.08	1.60	3.12	0.93	0.44	0.47	0.49	0.54	0.53	0.63	0.58
Interest Coverage TTM	-17.41	-23.30	-21.66	-20.80	-20.46	-12.32	-12.52	-13.17	-14.53	-14.72	-15.18	-15.46
Debt Ratio	0.44	0.52	0.61	0.77	0.48	0.31	0.32	0.33	0.35	0.35	0.39	0.37
Efficiency & Turnover
Asset Turnover TTM	0.13	0.13	0.13	0.12	0.11	0.09	0.09	0.09	0.06	0.07	0.08	0.07
Days Sales Outstanding TTM	14.59	12.58	19.17	8.98	8.21	5.54	26.57	17.52	20.00	3.51	21.26	17.98
Receivables Turnover TTM	25.02	29.01	19.04	40.66	44.46	65.91	13.74	20.83	18.25	103.94	17.17	20.31
Per Share Metrics
Diluted EPS TTM	-0.12	-0.25	-0.28	-0.30	-0.18	-0.07	-0.09	-0.11	-0.13	-0.13	-0.12	-0.13
Free Cash Flow Per Share TTM	-0.10	-0.09	-0.08	-0.09	-0.10	-0.10	-0.12	-0.12	-0.12	-0.13	-0.17	-0.18
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	-	-	-	-	-	97.15%	96.48%	95.00%	90.83%	91.88%	92.50%	94.11%
Operating Profit Margin TTM	-205.23%	-255.14%	-251.57%	-325.27%	-322.84%	-223.10%	-226.11%	-260.70%	-413.76%	-309.28%	-276.50%	-285.11%
Net Profit Margin TTM	-246.40%	-434.29%	-436.47%	-625.56%	-374.57%	-169.40%	-195.90%	-230.46%	-391.25%	-295.30%	-240.12%	-263.85%
Growth Metrics
Net Revenue Growth (1Y)	19.87%	54.64%	53.24%	24.05%	76.43%	19.42%	6.19%	-0.60%	-38.86%	-27.52%	-33.84%	-31.32%
Net Income Growth (1Y)	-21.14%	296.44%	241.41%	236.72%	68.91%	-31.49%	-13.36%	-13.18%	9.50%	-0.13%	-18.50%	-52.67%
EPS Growth (1Y)	-27.83%	265.74%	197.02%	177.84%	39.66%	-44.57%	-25.28%	-19.60%	-1.07%	-7.11%	-19.85%	-54.04%
Valuation Metrics
P/E TTM	-10.14	-6.03	-6.05	-5.72	-5.08	-6.28	-5.38	-8.55	-7.80	-11.45	-8.76	-8.92
P/B TTM	5.37	7.35	8.87	17.55	4.41	1.31	1.30	2.65	2.82	3.81	3.03	3.03
P/S TTM	24.98	26.20	26.40	35.76	19.04	10.64	10.54	19.71	30.52	33.83	21.04	23.52
Market Cap	326.84M	387.15M	384.29M	386.76M	207.80M	101.72M	100.10M	171.84M	188.81M	270.71M	188.20M	206.34M
Enterprise Value	289.49M	350.72M	343.04M	345.87M	165.13M	53.95M	53.86M	143.67M	158.76M	226.71M	152.35M	174.50M
Calculated Values
Free Cash Flow TTM	-24.39M	-22.59M	-19.44M	-20.88M	-23.15M	-22.82M	-23.66M	-23.06M	-22.33M	-23.63M	-29.24M	-31.45M
Net Debt	-37.36M	-36.42M	-41.26M	-40.89M	-42.68M	-47.78M	-46.23M	-28.17M	-30.06M	-43.99M	-35.85M	-31.85M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-03-12Purchase

Owner: Culley, Brian M

Title: President and CEO

Shares: 15,000

Price/Share: $1.63

Value: $24,450.00

Shares Owned: 255,516

Relationship: Director,Officer

Ownership: Direct

2025-01-27Purchase

Owner: Broadwood, Capital Inc, B…

Title: -

Shares: 7,894,737

Price/Share: $0.76

Value: $6,000,000.12

Shares Owned: 49,560,992

Relationship: Director,TenPercentOwner

Ownership: Direct

2024-11-26Purchase

Owner: Samuel, George A. Iii

Title: General Counsel

Shares: 15,000

Price/Share: $0.60

Value: $9,000.00

Shares Owned: 22,184

Relationship: Officer

Ownership: Direct

2024-11-26Purchase

Owner: Howe, Jill Ann

Title: Chief Financial Officer

Shares: 15,000

Price/Share: $0.59

Value: $8,850.00

Shares Owned: 25,500

Relationship: Officer

Ownership: Direct

2024-11-22Purchase

Owner: Mulroy, Michael H.

Title: -

Shares: 40,000

Price/Share: $0.57

Value: $22,800.00

Shares Owned: 298,555

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-03-12	Culley, Brian M	Director,Officer	President and CEO	Direct	Purchase	15,000	1.63	$24,450.00	255,516	4
2025-01-27	Broadwood, Capital Inc, B…	Director,TenPercentOwner	-	Direct	Purchase	7,894,737	0.76	$6,000,000.12	49,560,992	4
2024-11-26	Samuel, George A. Iii	Officer	General Counsel	Direct	Purchase	15,000	0.60	$9,000.00	22,184	4
2024-11-26	Howe, Jill Ann	Officer	Chief Financial Officer	Direct	Purchase	15,000	0.59	$8,850.00	25,500	4
2024-11-22	Mulroy, Michael H.	Director	-	Direct	Purchase	40,000	0.57	$22,800.00	298,555	4
2024-11-21	Culley, Brian M	Director,Officer	President and CEO	Direct	Purchase	40,000	0.60	$24,000.00	194,842	4
2024-08-16	Howe, Jill Ann	Officer	Chief Financial Officer	Direct	Purchase	10,500	0.89	$9,345.00	10,500	4
2024-05-24	Culley, Brian M	Director,Officer	President and CEO	Direct	Purchase	10,000	1.05	$10,500.00	154,842	4
2024-02-08	Bailey, Don M	Director	-	Indirect	Purchase	96,155	1.04	$100,001.20	158,801	4
2024-02-06	Broadwood, Partners, L.P.…	TenPercentOwner	-	Direct	Purchase	6,730,770	1.04	$7,000,000.80	41,666,255	4
2023-12-29	Jayasuriya, Anula	Director	-	Direct	Purchase	10,000	1.09	$10,900.00	10,000	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

45.36%

Inst. Shares: 111,153,671

Shares Outstanding: 245,029,000

2025-12-31

44.01%

Inst. Shares: 101,275,943

Shares Outstanding: 230,116,000

2025-09-30

38.06%

Inst. Shares: 87,091,398

Shares Outstanding: 228,853,000

2025-06-30

42.24%

Inst. Shares: 96,450,130

Shares Outstanding: 228,356,000

2025-03-31

84.05%

Inst. Shares: 190,007,514

Shares Outstanding: 226,054,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	111,153,671	245,029,000	45.36%
2025-12-31	101,275,943	230,116,000	44.01%
2025-09-30	87,091,398	228,853,000	38.06%
2025-06-30	96,450,130	228,356,000	42.24%
2025-03-31	190,007,514	226,054,000	84.05%
2024-12-31	106,111,956	200,193,000	53.00%
2024-09-30	93,987,148	188,835,000	49.77%
2024-06-30	94,021,638	188,813,000	49.80%
2024-03-31	92,499,833	182,909,000	50.57%
2023-12-31	75,056,425	172,663,000	43.47%
2023-09-30	75,145,570	174,868,000	42.97%
2023-06-30	74,528,752	170,592,000	43.69%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Lineage Cell Therapeutics, Inc. (LCTX) — SEC Financial Statements & Analysis

Lineage Cell Therapeutics, Inc. (LCTX) is a biological products, (no diagnostic substances) company, incorporated in CA. Lineage Cell Therapeutics, Inc. trades on NYSE as: LCTX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Lineage Cell Therapeutics, Inc. reported a 19.87% year-over-year revenue growth, a Gross Profit Margin of 97.15% (TTM), a Debt-to-Equity ratio of 0.76x, a Price-to-Sales (P/S) ratio of 24.98x (TTM), a Price-to-Book (P/B) ratio of 5.37x (TTM), at a market cap of $326.84M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 19.87%
Gross Profit Margin TTM: 97.15%
Debt To Equity: 0.76x
P/S TTM: 24.98x
P/B TTM: 5.37x
Market Cap: $326.84M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Lineage Cell Therapeutics, Inc. in?

Lineage Cell Therapeutics, Inc. (LCTX) operates in the Biological Products, (No Diagnostic Substances) industry.

What is LCTX's market cap?

Lineage Cell Therapeutics, Inc. (LCTX) has a market capitalization of $326.84M as of 2026-06-30.

What exchange does LCTX trade on?

Lineage Cell Therapeutics, Inc. (LCTX) trades on the NYSE.

Where is Lineage Cell Therapeutics, Inc. incorporated?

Lineage Cell Therapeutics, Inc. is incorporated in CA.